Journal's Global Impact Factor Records
The journal's Global Impact Factor (GIF) is calculated according to the standard formula published by Clarivate Analytics (previously ISI). The following is an example for calculation of 2020 GIF.

A = 43 citations (number of times articles published in 2019 and 2018, cited in 2020).
B = 81 articles (total number of articles published in 2019 and 2018).
A/B = 0.531 (GIF for 2020).

GIF for previous years were calculated using similar method and the value is announced in July of the relevant year. The journal was started in 2014.

NOTE: Raw data used in this calculation can be accessed from the journal’s citation records by Google Scholar for verifications by third parties.

GIF for 2020
A = 43 citations
B = 81 articles
GIF for 2017 = 0.531
H-Index = 10
= 15
GIF for 2019
A = 47 citations
B = 99 articles
GIF for 2017 = 0.475
H-Index = 7
= 3
GIF for 2018
A = 64 citations
B = 141 articles
GIF for 2017 = 0.454
H-Index = 6
= 1
GIF for 2017
A = 36 citations
B = 90 articles
GIF for 2017 = 0.400
H-Index = 4
= 0
IF for 2016
A = 6 citations
B = 20 articles
GIF for 2016 = 0.300
H-Index = 2
= 0
Floating ads


Current Issue - Vol 8, No 2, June 2021

Next Issue - Vol 8, No 2, June 2021

Most cited papers from Transactions on Science and Technology

Highlights from the Current Issue

Mycolytic Enzyme-Producing Bacteria Demonstrates Antifungal Activities Against Basal Stem Rot Disease Caused by Ganoderma boninense
Wee Shui Shui; Izzatie binti Musa; Kelvin Ling Wen Sin; Peter Morin Nissom. 2021. Transactions on Science and Technology, 8(2), 85 - 90.
Abstract The basal stem rot (BSR) disease of oil palm (Elaeis guineensis Jacq.) is caused by the white rot fungus, Ganoderma boninense (G. boninense). This study discusses the use of a biological control approach to treat BSR by using mycolytic enzymes producing bacteria as biocontrol agents against G. boninense. Bacteria producing mycolytic enzymes which degrade fungal cell wall were targeted. The antifungal properties of Acinetobactor calcoaceticus (A. calcoaceticus), Chryseobacterium indologenes (C. indologenes), and Pseudomonas putida (P. putida) were tested against G. boninense. The three strains showed the ability to inhibit the growth of G. boninense in dual culture test, culture filtrate test, double plate assay, and soft agar encapsulation. In dual culture test, all three test strains showed high Percentage Inhibition of Diameter Growth (PIDG) value with P. putida having the highest PIDG value of approximately 90%. As for culture filtrate test, C. indologenes demonstrated the highest PIDG value, approximately 85%. Double plate assay and soft agar encapsulation depicted the similar result for all three test strains which the PIDG value for both tests were 90%. The isolated strains exhibited promising results in anti-Ganoderma testing.
View article

Use of Traditional Chinese and Modern Medicines in the Treatment of COVID-19: A Minireview
Peik Lin Teoh; Jacqueline Tze Chin Wong. 2021. Transactions on Science and Technology, 8(2), 110 - 120.
Abstract COVID-19 pandemic has affected human life worldwide since the first discovery of human SARS-CoV-2 infection. Due to scarce understandings of this novel coronavirus, therapeutic interventions regardless of modern or traditional medicines are implemented according to previous knowledge on other virus outbreaks. Besides antiviral drugs, traditional Chinese medicine has concomitantly shown to alleviate clinical symptoms associated with this disease. Recently, emerging studies also indicate that integrating modern medicine and traditional Chinese medicine (TCM) could bring more significant benefits to COVID-19 patients. This minireview provides a summary on the earliest therapeutic approaches recommended by World Health Organization and approved by China FDA for COVID-19 treatment since the outbreak, which are based on the outcomes obtained from preclinical or clinical trials performed until December 2020. The underlying molecular actions of these medicines on COVID-19 that have progressively revealed are also deliberated here. However, the mechanistic actions of these medicines still required intensive research and clinical investigations as some mechanisms are in silico predicted. Due to the treatment urgency, the main limitation of these studies is small group of patients in the trials. Nevertheless, they serve as an important stepping stone for further therapeutic intervention.
View article

Article in press

Articles that are peer reviewed and have been accepted but are not yet assigned to a volume and issue. When the final article is assigned to an issue of the journal, the "Article in Press" version will be removed and will appear in the associated journal issue.

Currently no article in press available.

Small UniSE Press Logo